s6y
Company name or ticker
Search
Compass Therapeutics, Inc.
SC 14F1/A
Statement regarding change in majority of directors pursuant to Rule 14f-1
Filed
Thursday, May 28, 2020
Accession number
0001213900-20-013620
Documents
FORM SC 14F1/A
SC 14F1/A
On sec.gov
Filing index
All files
Complete submission text
SGML header